Anterior wall adenocarcinoma of bladder with similar clinicopathological and prognostic characteristics as common bladder carcinomas should not be treated as or classified into urachal adenocarcinomas

To discuss whether the dome or anterior wall of bladder adenocarcinoma (BAC) should be classified into urachal carcinoma (UrC) and the relationship of primary tumor location (PTL) as well as treatment with survival.

[1]  G. Procopio,et al.  Current Understanding of Urachal Adenocarcinoma and Management Strategy , 2020, Current Oncology Reports.

[2]  L. Krane,et al.  Reviewing the Demographic, Prognostic, and Treatment Factors of Primary Adenocarcinoma of the Bladder: A SEER Population-based Study. , 2019, Clinical genitourinary cancer.

[3]  G. Procopio,et al.  Urachal carcinoma: Towards a precision medicine , 2016 .

[4]  Y. Lotan,et al.  Effect of tumor location on survival in urinary bladder adenocarcinoma: A population-based analysis. , 2016, Urologic oncology.

[5]  M. Amin,et al.  Updates in the Pathologic Diagnosis and Classification of Epithelial Neoplasms of Urachal Origin , 2016, Advances in anatomic pathology.

[6]  B. Czerniak,et al.  Urachal carcinoma: a pathologic and clinical study of 46 cases. , 2015, Human pathology.

[7]  W. Choi,et al.  Glandular Neoplasms of the Urachus: A Report of 55 Cases Emphasizing Mucinous Cystic Tumors With Proposed Classification , 2014, The American journal of surgical pathology.

[8]  Jingbo Wu,et al.  Options for diagnosis and treatment of urachal carcinoma , 2013, Asia-Pacific journal of clinical oncology.

[9]  L. Kiemeney,et al.  The clinical epidemiology of urachal carcinoma: results of a large, population based study. , 2012, The Journal of urology.

[10]  A. Siefker-Radtke.  Urachal adenocarcinoma: a clinician's guide for treatment. , 2012, Seminars in oncology.

[11]  R. Dorin,et al.  Pediatric Urology: Surgical Complications and Management , 2009 .

[12]  E. Cheng.  Pediatric Urology: Surgical Complications and Management, D.T. Wilcox, P.P. Godbole, M.A. Koyle. Wiley-Blackwell, Hoboken, New Jersey (2008), 386 pages , 2009 .

[13]  V. Reuter,et al.  Urachal Carcinoma: A Clinicopathologic Analysis of 24 Cases With Outcome Correlation , 2009, The American journal of surgical pathology.

[14]  Yair Lotan,et al.  Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy , 2008, Cancer.

[15]  Wun-Jae Kim.  Multiple biomarkers improve prediction of bladder cancer progression and cancer specific survival , 2008 .

[16]  V. Reuter,et al.  Urachal carcinoma: contemporary surgical outcomes. , 2007, The Journal of urology.

[17]  B. Leibovich,et al.  Urachal carcinoma: Clinicopathologic features and long‐term outcomes of an aggressive malignancy , 2006, Cancer.

[18]  P. Lange,et al.  Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder , 2006, Cancer.

[19]  I. Sesterhenn,et al.  World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs , 2005 .

[20]  R. Millikan,et al.  Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience. , 2003, The Journal of urology.

[21]  P. Bassi,et al.  Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort. , 1999, The Journal of urology.